HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Normal-appearing captopril MAG-3 renal scintigraphy in hemodynamically significant renal artery stenosis. A case report.

Abstract
The finding from a normal-appearing angiotensin converting enzyme (ACE)-inhibitor renal scan is generally reassuring to the physician screening for renovascular hypertension. In fact, the false-negative rate for captopril scintigraphy is very low. Possible reasons for false-negative scans have not been well documented. A fifty-two-year-old man was evaluated and found to have renovascular hypertension on two occasions, at initial presentation and again eight months later (restenosis had occurred). Renovascular hypertension was present on both occasions as judged by decline of blood pressure following angioplasty of right renal artery stenosis (approximately 80% and approximately 70% stenosis on the two occasions, respectively). However, ACE-inhibitor renal scanning with 99mTc MAG-3 gave disparate results on the two occasions. The first study using oral captopril (25 mg) indicated a low probability of renal artery stenosis, whereas the second study done with the patient regularly taking lisinopril (10 mg daily) was markedly positive. Possible reasons for the initial negative study include poor absorption of oral captopril or inadequate inhibition of the renin-angiotensin system by the 25 mg dose.
AuthorsG A Mansoor, W B White, N C Friedman
JournalAngiology (Angiology) Vol. 46 Issue 10 Pg. 929-35 (Oct 1995) ISSN: 0003-3197 [Print] United States
PMID7486214 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Organotechnetium Compounds
  • N-(mercaptoacetyl)glycine
  • Captopril
  • Glycine
Topics
  • Captopril
  • False Negative Reactions
  • Glycine (analogs & derivatives)
  • Humans
  • Male
  • Middle Aged
  • Organotechnetium Compounds (therapeutic use)
  • Radiography
  • Radionuclide Imaging
  • Renal Artery Obstruction (diagnostic imaging, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: